12-2685771-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_000719.7(CACNA1C):​c.5609C>T​(p.Thr1870Met) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1870K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0010 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

CACNA1C
NM_000719.7 missense

Scores

1
1
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 6.01

Publications

23 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057109594).
BP6
Variant 12-2685771-C-T is Benign according to our data. Variant chr12-2685771-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 191567.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.5609C>Tp.Thr1870Met
missense
Exon 44 of 47NP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.5609C>Tp.Thr1870Met
missense
Exon 44 of 47NP_001161095.1Q13936-37
CACNA1C
NM_199460.4
c.5858C>Tp.Thr1953Met
missense
Exon 47 of 50NP_955630.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.5609C>Tp.Thr1870Met
missense
Exon 44 of 47ENSP00000382512.1Q13936-37
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.5609C>Tp.Thr1870Met
missense
Exon 44 of 47ENSP00000382563.1Q13936-12
CACNA1C
ENST00000682544.1
c.5948C>Tp.Thr1983Met
missense
Exon 47 of 50ENSP00000507184.1A0A804HIR0

Frequencies

GnomAD3 genomes
AF:
0.00102
AC:
145
AN:
141892
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00106
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000696
Gnomad ASJ
AF:
0.000309
Gnomad EAS
AF:
0.00187
Gnomad SAS
AF:
0.00153
Gnomad FIN
AF:
0.00209
Gnomad MID
AF:
0.00360
Gnomad NFE
AF:
0.000863
Gnomad OTH
AF:
0.000526
GnomAD2 exomes
AF:
0.00102
AC:
252
AN:
246240
AF XY:
0.000942
show subpopulations
Gnomad AFR exome
AF:
0.000131
Gnomad AMR exome
AF:
0.000408
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000676
Gnomad FIN exome
AF:
0.00697
Gnomad NFE exome
AF:
0.000394
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000658
AC:
946
AN:
1437826
Hom.:
1
Cov.:
31
AF XY:
0.000654
AC XY:
468
AN XY:
715836
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000182
AC:
6
AN:
32974
American (AMR)
AF:
0.000384
AC:
17
AN:
44236
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25912
East Asian (EAS)
AF:
0.000738
AC:
29
AN:
39316
South Asian (SAS)
AF:
0.000902
AC:
77
AN:
85330
European-Finnish (FIN)
AF:
0.00517
AC:
269
AN:
52050
Middle Eastern (MID)
AF:
0.000363
AC:
2
AN:
5514
European-Non Finnish (NFE)
AF:
0.000467
AC:
510
AN:
1093058
Other (OTH)
AF:
0.000606
AC:
36
AN:
59436
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.346
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00102
AC:
145
AN:
142000
Hom.:
1
Cov.:
32
AF XY:
0.00103
AC XY:
71
AN XY:
69258
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00106
AC:
41
AN:
38660
American (AMR)
AF:
0.000695
AC:
10
AN:
14390
Ashkenazi Jewish (ASJ)
AF:
0.000309
AC:
1
AN:
3236
East Asian (EAS)
AF:
0.00188
AC:
9
AN:
4796
South Asian (SAS)
AF:
0.00153
AC:
7
AN:
4580
European-Finnish (FIN)
AF:
0.00209
AC:
20
AN:
9568
Middle Eastern (MID)
AF:
0.00388
AC:
1
AN:
258
European-Non Finnish (NFE)
AF:
0.000863
AC:
55
AN:
63732
Other (OTH)
AF:
0.000522
AC:
1
AN:
1916
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.330
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0938
Hom.:
3188
ExAC
AF:
0.00352
AC:
426
EpiCase
AF:
0.000439
EpiControl
AF:
0.000357

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
3
not specified (3)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Long QT syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.080
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.013
T
Eigen
Benign
0.18
Eigen_PC
Benign
0.12
FATHMM_MKL
Pathogenic
0.99
D
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-0.73
T
PhyloP100
6.0
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.15
Sift
Benign
0.10
T
Sift4G
Benign
0.23
T
Polyphen
0.99
D
Vest4
0.49
MVP
0.52
MPC
0.33
ClinPred
0.029
T
GERP RS
4.3
gMVP
0.39
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201777030; hg19: chr12-2794937; COSMIC: COSV59698677; COSMIC: COSV59698677; API